Table 2.
Baseline and echocardiographic characteristics according to presence of MSIMI
| Characteristic | No MSIMI N=127 |
MSIMI N=98 |
p-value |
|---|---|---|---|
| Age | 63.5 ±10.0 | 62.8 ±10.0 | 0.5861 |
| Race, white | 109 (85.8) | 80 (81.6) | 0.5045 |
| Female gender | 17 (13.4) | 20 (20.4) | 0.2196 |
| BMI, kg/m2 | 29.0 ±4.5 | 28.4 ±4.5 | 0.3256 |
| Living arrangements, alone | 15 (11.8) | 19 (19.4) | 0.1658 |
| Marital status, not married | 23 (18.1) | 27 (27.6) | 0.1267 |
| Current smoker | 12 (9.4) | 16 (16.3) | 0.2302 |
| Current medical therapy | |||
| ASA | 121 (96.0) | 94 (96.9) | 1.0000 |
| Other antiplatelet agent | 50 (39.4) | 46 (47.4) | 0.2844 |
| ACEi | 79 (62.2) | 62 (63.9) | 0.9018 |
| ARB | 15 (11.9) | 17 (17.5) | 0.3201 |
| Beta-blocker | 103 (81.1) | 82 (84.5) | 0.6215 |
| Calcium channel blocker | 29 (23.0) | 20 (20.6) | 0.7906 |
| Statin | 113 (89.7) | 92 (95.8) | 0.1463 |
| History of MI | 51 (40.2) | 47 (48.0) | 0.4844 |
| History of CABG | 51 (40.2) | 43 (43.9) | 0.6711 |
| History of PCI | 79 (62.2) | 64 (65.3) | 0.7342 |
| History of DM | 38 (29.9) | 25 (25.5) | 0.7342 |
| History of HTN | 102 (80.3) | 74 (75.5) | 0.4821 |
| History of hyperlipidemia | 119 (93.7) | 91 (92.9) | 1.0000 |
| NYHA functional class | |||
| I | 115 (90.6) | 90 (91.8) | |
| II | 8 (6.3) | 7 (7.1) | 0.7053 |
| III | 4 (4.1) | 1 (1.0) | |
| History of depression | 15 (11.8) | 13 (13.3) | 0.9013 |
| Resting LVEF, % | 58.7 ±8.2 | 57.8 ±10.3 | 0.4817 |
| Resting WMSI | 1.11 ±0.28 | 1.19 ±0.34 | 0.0725 |
| Resting MV dec time, ms | 228.1 ±58.2 | 232.6 ±60.0 | 0.5726 |
| Resting E/A ratio | 0.97 ±0.34 | 1.00 ±0.30 | 0.4976 |
| Resting E/e′ | 11.7 ±4.2 | 12.2 ±4.7 | 0.4785 |
| Resting eas-index | 0.09 ±0.03 | 0.11 ±0.04 | < 0.0001 |